Spruce Biosciences, Inc. (SPRB)
NASDAQ: SPRB · Real-Time Price · USD
53.00
-1.20 (-2.22%)
Mar 3, 2026, 11:33 AM EST - Market open
Spruce Biosciences Market Cap
Spruce Biosciences has a market cap or net worth of $56.73 million as of March 3, 2026. Its market cap has increased by 234.84% in one year.
Market Cap
56.73M
Enterprise Value
48.70M
1-Year Change
234.84%
Ranking
Category
Stock Price
$53.00
Market Cap Chart
Since October 9, 2020, Spruce Biosciences's market cap has decreased from $378.48M to $56.73M, a decrease of -85.01%. That is a compound annual growth rate of -29.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 2, 2026 | 58.02M | -37.77% |
| Dec 31, 2025 | 93.24M | 437.50% |
| Dec 31, 2024 | 17.35M | -85.46% |
| Dec 29, 2023 | 119.28M | 361.35% |
| Dec 30, 2022 | 25.86M | -75.29% |
| Dec 31, 2021 | 104.65M | -81.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 9, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alterity Therapeutics | 61.44M |
| Grace Therapeutics | 61.35M |
| InflaRx | 60.82M |
| TScan Therapeutics | 60.72M |
| NRx Pharmaceuticals | 58.01M |
| MAIA Biotechnology | 57.21M |
| ImmuCell | 56.17M |
| Rallybio | 55.44M |